CAMBRIDGE, MA—BioMed Realty Trust has put together a new ten-year lease with Biogen for approximately 80,000 square feet of class A laboratory and office space at the company's 301 Binney Street property. Biogen develops, markets and manufactures therapies for people living with serious neurological, autoimmune and hematologic disorders and will use this new space to expand its drug discovery efforts in this core life science district and is among the largest and fastest growing global life science companies based in Massachusetts.

With the lease of the fifth floor to Biogen, BioMed Realty has fully leased the 417,000 square foot 301 Binney Street property. Biogen joins Ironwood Pharmaceuticals and Living Proof located at this prime laboratory and office building.

“BioMed Realty is pleased to welcome Biogen to our growing list of tenants in Cambridge, and we look forward to building a long relationship with such a strong player in the Kendall Square research community,” said Bill Kane, SVP for BioMed Realty in Boston/Cambridge. “We are seeing a growing demand for life science real estate, especially quality laboratory space, here in Cambridge, and we are focused on developing and leasing this unique type of real estate to companies like Biogen, Baxter Healthcare and the growing number of new biotech companies seeking to develop breakthrough therapies in strategic locations.”